J. Scott Wolchko - 10 Jan 2022 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Signature
/s/ Cindy Tahl, Attorney-in-Fact
Issuer symbol
FATE
Transactions as of
10 Jan 2022
Net transactions value
-$1,600,534
Form type
4
Filing time
12 Jan 2022, 15:07:58 UTC
Previous filing
22 Nov 2021
Next filing
13 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Sale $610,144 -13,161 -2.7% $46.36* 467,107 10 Jan 2022 Direct F1, F2
transaction FATE Common Stock Sale $985,570 -20,894 -4.5% $47.17* 446,213 10 Jan 2022 Direct F1, F3
transaction FATE Common Stock Sale $4,820 -101 -0.02% $47.72* 446,112 10 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 62,500 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2 Represents the weighted average sale price of the shares sold ranging from $45.72 to $46.70 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 3.
F3 Represents the weighted average sale price of the shares sold ranging from $46.72 to $47.67 per share.